The US Supreme Court heard the most high-profile genetics case in history on Monday, as justices considered whether private firms should be allowed to patent human genes linked to breast cancer. Opponents of Myriad Genetics' patenting of genes associated with breast and ovarian cancer argued outside court that gene-patenting stifles scientific research, limits women health choices and wrongly gives corporate control over part of the human body.Duration: 00:41